NVST Envista Holdings Corp
Healthcare$23.50+0.30%ClosedMarket Cap: $3.82B
As of 2026-05-26
Valuation
P/E (TTM)
88.48
PEG
0.85
P/B
1.25
P/S
1.36
EV/EBITDA
12.63
DCF Value
$48.31
FCF Yield
5.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
55.1%
Operating Margin
9.0%
Net Margin
2.4%
ROE
2.2%
ROA
1.2%
ROIC
1.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $705.5M | 55.3% | $62.5M | $38.7M | $— | — |
| Q4 null | $750.6M | 55.0% | $75.8M | $32.9M | $— | — |
| FY null | $2.72B | 55.0% | $225.7M | $47.0M | $— | — |
| Q3 null | $669.9M | 56.0% | $64.8M | $-30.3M | $— | — |
| Q2 null | $682.1M | 54.3% | $50.8M | $26.4M | $— | — |
| Q1 null | $616.9M | 54.5% | $39.0M | $18.0M | $— | — |
| Q4 null | $652.9M | 57.2% | $46.1M | $1.2M | $— | — |
| FY null | $2.51B | 55.4% | $-1.04B | $-1.12B | $— | — |
| Q3 null | $601.0M | 52.8% | $20.9M | $8.2M | $— | — |
| Q2 null | $633.1M | 52.1% | $-1.15B | $-1.15B | $— | — |
| Q1 null | $623.6M | 57.4% | $48.1M | $23.6M | $— | — |
| Q4 2023 | $645.6M | 52.4% | $-202.8M | $-217.4M | $-1.27 | — |